HUMAN EPIDERMAL GROWTH-FACTOR - DISTINCT ROLES OF TYROSINE-37 AND ARGININE-41 IN RECEPTOR-BINDING AS DETERMINED BY SITE-DIRECTED MUTAGENESIS AND NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY

被引:65
作者
ENGLER, DA
MONTELIONE, GT
NIYOGI, SK
机构
[1] UNIV TENNESSEE,OAK RIDGE GRAD SCH BIOMED SCI,DIV BIOL,OAK RIDGE NATL LAB,POB 2009,OAK RIDGE,TN 37831
[2] UNIV TENNESSEE,OAK RIDGE GRAD SCH BIOMED SCI,PROT ENGN & MOLEC MUTAGENESIS PROGRAM,OAK RIDGE,TN 37831
[3] RUTGERS STATE UNIV,CTR ADV BIOTECHNOL & MED,PISCATAWAY,NJ 08854
[4] RUTGERS STATE UNIV,DEPT CHEM,PISCATAWAY,NJ 08854
关键词
Epidermal growth factor; Protein engineering; Rational drug design; Receptor affinity; Structure by NMR;
D O I
10.1016/0014-5793(90)80368-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Site-directed mutagenesis was employed to examine the function of two highly conserved residues, Tyr-37 and Arg-41, of human EGF (hEGF) in receptor binding. Both a conservative change to phenylalanine and a semi-conservative change to histidine at position 37 yield proteins with receptor affinity similar to wild-type hEGF. A non-conservative change to alanine results in a molecule with about 40% of the receptor affinity, indicating that an aromatic residue is not essential at this position. Both conservative (to lysine) and non-conservative (to alanine) substitutions at position 41 drastically reduced receptor binding to <0.5% of the wild-type activity. 1D-NMR data indicate that the replacement of Arg-41 by lysine does not significantly alter the native protein conformation. Thus, Arg-41 may be directly involved in ligand-receptor interaction, whereas the side chain of Tyr-37, although possibly important structurally, is not essential for receptor binding. © 1990.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 22 条
[1]   PURIFICATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR BY TYROSINE-SEPHAROSE AFFINITY-CHROMATOGRAPHY [J].
AKIYAMA, T ;
KADOOKA, T ;
OGAWARA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (01) :442-448
[2]   EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH FACTOR-ALPHA [J].
BURGESS, AW .
BRITISH MEDICAL BULLETIN, 1989, 45 (02) :401-424
[3]  
CARPENTER G, 1990, J BIOL CHEM, V265, P7709
[4]  
CARPENTER G, 1985, METHOD ENZYMOL, V109, P107
[5]  
Carpenter G., 1990, HDB EXPT PHARM, P69
[6]   THE SOLUTION STRUCTURE OF HUMAN EPIDERMAL GROWTH-FACTOR [J].
COOKE, RM ;
WILKINSON, AJ ;
BARON, M ;
PASTORE, A ;
TAPPIN, MJ ;
CAMPBELL, ID ;
GREGORY, H ;
SHEARD, B .
NATURE, 1987, 327 (6120) :339-341
[7]   STRUCTURE-FUNCTION ANALYSIS OF SYNTHETIC AND RECOMBINANT DERIVATIVES OF TRANSFORMING GROWTH FACTOR-ALPHA [J].
DEFEOJONES, D ;
TAI, JY ;
WEGRZYN, RJ ;
VUOCOLO, GA ;
BAKER, AE ;
PAYNE, LS ;
GARSKY, VM ;
OLIFF, A ;
RIEMEN, MW .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) :2999-3007
[8]   SUBSTITUTION OF LYSINE FOR ARGININE AT POSITION-42 OF HUMAN TRANSFORMING GROWTH FACTOR-ALPHA ELIMINATES BIOLOGICAL-ACTIVITY WITHOUT CHANGING INTERNAL DISULFIDE BONDS [J].
DEFEOJONES, D ;
TAI, JY ;
VUOCOLO, GA ;
WEGRZYN, RJ ;
SCHOFIELD, TL ;
RIEMEN, MW ;
OLIFF, A .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (09) :4083-4086
[9]   STRUCTURE-FUNCTION ANALYSIS OF EPIDERMAL GROWTH-FACTOR - SITE DIRECTED MUTAGENESIS AND NUCLEAR-MAGNETIC-RESONANCE [J].
DUDGEON, TJ ;
COOKE, RM ;
BARON, M ;
CAMPBELL, ID ;
EDWARDS, RM ;
FALLON, A .
FEBS LETTERS, 1990, 261 (02) :392-396
[10]  
ENGLER DA, 1988, J BIOL CHEM, V263, P12384